Prostate cancer (PCa) is the most common worldwide diagnosed malignancy in male
population. The diagnosis, the identification of aggressive disease, and the post-treatment …

Radiomics and genomics represent two of the most promising fields of cancer research,
designed to improve the risk stratification and disease management of patients with prostate …

Prostate cancer (PCa) is one of the most frequently diagnosed malignancies of men in the
world. Due to a variety of treatment options in different risk groups, proper diagnostic and …

The present study aimed to explore the potential of artificial intelligence (AI) methodology
based on magnetic resonance (MR) images to aid in the management of prostate cancer …

Multiparametric prostate magnetic resonance imaging (mpMRI) is widely used as a triage
test for men at a risk of prostate cancer. However, the traditional role of mpMRI was confined …

We present the current clinical applications of radiomics in the context of prostate cancer
(PCa) management. Several online databases for original articles using a combination of …

Purpose To develop a CT-based radiomic signature to predict biochemical recurrence
(BCR) in prostate cancer patients after sRT guided by positron-emission tomography …

Background With the development of imaging technology, an increasing number of
pulmonary nodules have been found. Some pulmonary nodules may gradually grow and …

The development of precise medical imaging has facilitated the establishment of radiomics,
a computer-based method of quantitatively analyzing subvisual imaging characteristics. The …

Prostate cancer (PCa) is a pernicious tumor with high heterogeneity, which creates a
conundrum for making a precise diagnosis and choosing an optimal treatment approach …